BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31071709)

  • 1. 5-Hydroxyhexanoic Acid Predicts Early Renal Functional Decline in Type 2 Diabetes Patients with Microalbuminuria.
    Tang X; You J; Liu D; Xia M; He L; Liu H
    Kidney Blood Press Res; 2019; 44(2):245-263. PubMed ID: 31071709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine proteome analysis by C18 plate-matrix-assisted laser desorption/ionization time-of-flight mass spectrometry allows noninvasive differential diagnosis and prediction of diabetic nephropathy.
    Chen CJ; Liao WL; Chang CT; Liao HY; Tsai FJ
    PLoS One; 2018; 13(7):e0200945. PubMed ID: 30024955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel urinary protein biomarkers predicting the development of microalbuminuria and renal function decline in type 1 diabetes.
    Schlatzer D; Maahs DM; Chance MR; Dazard JE; Li X; Hazlett F; Rewers M; Snell-Bergeon JK
    Diabetes Care; 2012 Mar; 35(3):549-55. PubMed ID: 22238279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in urine proteome accompanying diabetic nephropathy progression.
    Lewandowicz A; Bakun M; Kohutnicki R; Fabijańska A; Kistowski M; Imiela J; Dadlez M
    Pol Arch Med Wewn; 2015; 125(1-2):27-38. PubMed ID: 25578432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate.
    Nosadini R; Velussi M; Brocco E; Bruseghin M; Abaterusso C; Saller A; Dalla Vestra M; Carraro A; Bortoloso E; Sambataro M; Barzon I; Frigato F; Muollo B; Chiesura-Corona M; Pacini G; Baggio B; Piarulli F; Sfriso A; Fioretto P
    Diabetes; 2000 Mar; 49(3):476-84. PubMed ID: 10868971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus.
    Pena MJ; Lambers Heerspink HJ; Hellemons ME; Friedrich T; Dallmann G; Lajer M; Bakker SJ; Gansevoort RT; Rossing P; de Zeeuw D; Roscioni SS
    Diabet Med; 2014 Sep; 31(9):1138-47. PubMed ID: 24661264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay.
    Comper WD; Osicka TM; Clark M; MacIsaac RJ; Jerums G
    Kidney Int; 2004 May; 65(5):1850-5. PubMed ID: 15086926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics window into the role of acute kidney injury after coronary artery bypass grafting in diabetic nephropathy progression.
    Wang J; Yan W; Zhou X; Liu Y; Tang C; Peng Y; Liu H; Sun L; Xiao L; He L
    PeerJ; 2020; 8():e9111. PubMed ID: 32461830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine Tricarboxylic Acid Cycle Metabolites Predict Progressive Chronic Kidney Disease in Type 2 Diabetes.
    Liu JJ; Liu S; Gurung RL; Ching J; Kovalik JP; Tan TY; Lim SC
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4357-4364. PubMed ID: 30060124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine IgM-excretion as a prognostic marker for progression of type 2 diabetic nephropathy.
    Tofik R; Torffvit O; Rippe B; Bakoush O
    Diabetes Res Clin Pract; 2012 Jan; 95(1):139-44. PubMed ID: 22078636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria.
    Merchant ML; Perkins BA; Boratyn GM; Ficociello LH; Wilkey DW; Barati MT; Bertram CC; Page GP; Rovin BH; Warram JH; Krolewski AS; Klein JB
    J Am Soc Nephrol; 2009 Sep; 20(9):2065-74. PubMed ID: 19643930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
    Vijay S; Hamide A; Senthilkumar GP; Mehalingam V
    Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus.
    Satirapoj B; Tassanasorn S; Charoenpitakchai M; Supasyndh O
    PLoS One; 2015; 10(4):e0124055. PubMed ID: 25884625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Urinary Metabolite Biomarkers of Type 2 Diabetes Nephropathy Using an Untargeted Metabolomic Approach.
    Chen CJ; Liao WL; Chang CT; Lin YN; Tsai FJ
    J Proteome Res; 2018 Nov; 17(11):3997-4007. PubMed ID: 30265543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary Haptoglobin Predicts Rapid Renal Function Decline in Asians With Type 2 Diabetes and Early Kidney Disease.
    Liu JJ; Liu S; Wong MD; Gurung RL; Lim SC
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3794-3802. PubMed ID: 27459536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between methylation levels of targeted genes and albuminuria in patients with early diabetic kidney disease.
    Aldemir O; Turgut F; Gokce C
    Ren Fail; 2017 Nov; 39(1):597-601. PubMed ID: 28805547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels and Clinical Significances of Glypican-5 in Urine of Type 2 Diabetic Nephropathy Cases.
    Li R; Zhang L; Zhang S; Yang H; Yao B; Dong W; Zhang B; Chen Y; Liu S; Zhao X; Zhang Q; Shi W; Liang X
    Iran J Kidney Dis; 2019 May; 13(3):173-181. PubMed ID: 31209190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of nephropathy predictors in urine from children with a recent diagnosis of type 1 diabetes.
    Magagnotti C; Zerbini G; Fermo I; Carletti RM; Bonfanti R; Vallone F; Andolfo A
    J Proteomics; 2019 Feb; 193():205-216. PubMed ID: 30366120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential metabolomic signatures of declining renal function in Types 1 and 2 diabetes.
    Manca ML; Solini A; Haukka JK; Sandholm N; Forsblom C; Groop PH; Ferrannini E
    Nephrol Dial Transplant; 2021 Sep; 36(10):1859-1866. PubMed ID: 32995893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
    Nowak N; Skupien J; Smiles AM; Yamanouchi M; Niewczas MA; Galecki AT; Duffin KL; Breyer MD; Pullen N; Bonventre JV; Krolewski AS
    Kidney Int; 2018 May; 93(5):1198-1206. PubMed ID: 29398132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.